Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,220 | 74 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $311.91 | 18 | $0 (2024) |
| Galderma Laboratories, L.P. | $191.43 | 15 | $0 (2023) |
| Sun Pharmaceutical Industries Inc. | $134.27 | 7 | $0 (2023) |
| GENZYME CORPORATION | $91.98 | 4 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $78.46 | 4 | $0 (2023) |
| LEO Pharma Inc. | $66.84 | 4 | $0 (2023) |
| MAYNE PHARMA INC. | $63.33 | 4 | $0 (2022) |
| Amgen Inc. | $50.65 | 3 | $0 (2023) |
| Janssen Biotech, Inc. | $45.84 | 3 | $0 (2023) |
| Promius Pharma LLC | $43.21 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $72.29 | 3 | ABBVIE INC. ($72.29) |
| 2023 | $133.44 | 7 | Janssen Biotech, Inc. ($33.73) |
| 2022 | $287.87 | 16 | ABBVIE INC. ($116.99) |
| 2021 | $252.38 | 17 | AbbVie Inc. ($61.93) |
| 2020 | $120.81 | 7 | AbbVie Inc. ($37.31) |
| 2019 | $77.75 | 5 | AbbVie, Inc. ($23.39) |
| 2018 | $150.81 | 11 | Galderma Laboratories, L.P. ($58.43) |
| 2017 | $124.82 | 8 | Promius Pharma LLC ($31.18) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: IMMUNOLOGY | ||||||
| 05/25/2023 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: Dermatology | ||||||
| 03/27/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Immunology | ||||||
| 02/17/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $21.56 | General |
| 02/09/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Immunology | ||||||
| 01/20/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/12/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Inflammation | ||||||
| 01/06/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: DERMATOLOGY | ||||||
| 12/15/2022 | MAYNE PHARMA INC. | — | Food and Beverage | In-kind items and services | $20.35 | General |
| 12/08/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: IMMUNOLOGY | ||||||
| 12/01/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Dermatology | ||||||
| 11/17/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/03/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: DERMATOLOGY | ||||||
| 10/27/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: IMMUNOLOGY | ||||||
| 09/08/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: IMMUNOLOGY | ||||||
| 07/14/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: IMMUNOLOGY | ||||||
| 07/07/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Immunology | ||||||
| 06/02/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: Immunology | ||||||
| 05/19/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/14/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: IMMUNOLOGY | ||||||
| 03/10/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: DERMATOLOGY | ||||||
| 02/17/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: DERMATOLOGY | ||||||
| 02/03/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 438 | 780 | $43,073 | $15,426 |
| 2022 | 8 | 870 | 1,650 | $96,988 | $42,176 |
| 2021 | 8 | 881 | 1,778 | $99,040 | $42,045 |
| 2020 | 14 | 1,173 | 2,261 | $138,425 | $60,161 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 103 | 113 | $15,820 | $6,121 | 38.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 106 | 119 | $10,125 | $2,470 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 56 | $6,655 | $2,446 | 36.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 62 | 65 | $4,608 | $1,962 | 42.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 94 | 407 | $3,362 | $1,708 | 50.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 20 | 20 | $2,503 | $719.52 | 28.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 208 | 240 | $34,750 | $16,211 | 46.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 213 | 264 | $23,317 | $6,987 | 30.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 123 | 141 | $10,242 | $5,242 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 100 | $11,820 | $5,209 | 44.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 183 | 848 | $7,288 | $4,021 | 55.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 15 | 16 | $3,659 | $1,867 | 51.0% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 15 | 15 | $2,530 | $1,383 | 54.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 24 | 26 | $3,383 | $1,255 | 37.1% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 187 | 225 | $32,499 | $15,135 | 46.6% |
| 17000 | Destruction of skin growth | Office | 2021 | 220 | 274 | $23,698 | $6,761 | 28.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 95 | 106 | $12,886 | $5,910 | 45.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 123 | 140 | $10,078 | $4,679 | 46.4% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 191 | 964 | $7,899 | $4,302 | 54.5% |
| 17281 | Destruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth | Office | 2021 | 16 | 19 | $4,363 | $2,016 | 46.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 38 | 39 | $5,114 | $1,938 | 37.9% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2021 | 11 | 11 | $2,504 | $1,303 | 52.1% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 242 | 284 | $40,329 | $17,994 | 44.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 200 | 236 | $22,928 | $11,255 | 49.1% |
| 17000 | Destruction of skin growth | Office | 2020 | 267 | 337 | $28,708 | $8,419 | 29.3% |
About Dr. Robert Griffith, MD
Dr. Robert Griffith, MD is a Dermatology healthcare provider based in Northport, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265472195.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Griffith, MD has received a total of $1,220 in payments from pharmaceutical and medical device companies, with $72.29 received in 2024. These payments were reported across 74 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,220).
As a Medicare-enrolled provider, Griffith has provided services to 3,362 Medicare beneficiaries, totaling 6,469 services with total Medicare billing of $159,808. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Northport, AL
- Active Since 06/08/2006
- Last Updated 10/08/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1265472195
Products in Payments
- SKYRIZI (Biological) $188.05
- DUPIXENT (Biological) $114.85
- EPIDUO FORTE (Drug) $109.99
- RINVOQ (Biological) $56.23
- Otezla (Drug) $50.65
- AKLIEF (Drug) $46.86
- REMICADE (Biological) $45.84
- ILUMYA (Biological) $45.05
- Ilumya (Biological) $43.00
- DORYX (Drug) $42.98
- ADBRY (Biological) $36.39
- HUMIRA (Biological) $33.20
- ENSTILAR (Drug) $30.45
- Trianex (Drug) $27.46
- EUCRISA (Drug) $24.68
- ACZONE (Drug) $24.13
- Humira (Biological) $23.39
- BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 (Device) $22.76
- DUPIXENT (Drug) $19.23
- Seysara (Drug) $19.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Northport
Dr. Jeffery Weeks, Md, MD
Dermatology — Payments: $15,948
Catherine Lucas, Md, MD
Dermatology — Payments: $11,773
Dr. Karen Walker, M.d, M.D
Dermatology — Payments: $9,998
Dr. Adam Richardson, Do, Faad, DO, FAAD
Dermatology — Payments: $7,542
Dr. Charles Gambla, Md, MD
Dermatology — Payments: $5,828
Mrs. Alicia Nichols, Crnp, CRNP
Dermatology — Payments: $5,385